Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr₹2,409 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹1,858 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr
Mar2020₹2,409 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr
6.77
Mar2020 ₹2,409 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹42,678.5 Cr 3% -1.6% 70.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,050.0 Cr 2.7% 0.9% 34.7% Stock Analytics
DIVIS LABORATORIES ₹155,208.0 Cr -1.1% 1.1% 57.7% Stock Analytics
CIPLA ₹117,197.0 Cr 0.6% -1.7% 8.4% Stock Analytics
DR REDDYS LABORATORIES ₹107,586.0 Cr -1.6% -4.6% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,496.4 Cr -0.5% 2.5% 36% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3%

-1.6%

70.8%

SENSEX

-0.7%

-2.6%

7.5%


You may also like the below Video Courses